Glutethimide Market, Global Outlook and Forecast 2022-2028

May 2022 | 60 pages | ID: GE756C3F8EBDEN
Market Monitor Global

Abstracts

Glutethimide is a hypnotic sedative drug which is a safe alternative to barbiturates for treatment of insomnia. It mainly used for patients to feel sleepy and make them calm. Glutethimide is highly lipophilic and concentrates in adipose tissue and brain. It is an alternative for barbiturates. It undergoes extensive metabolism in liver with both unconjugated and conjugated metabolites which kidney excretes. Glutethimide is a CYP2D6 enzyme inducer and when it taken with codeine, it enables the body to convert high amount of codeine to morphine. The most common brand name for glutethimide are ciba, glue, and gofers. It is categorized as schedule II drug under psychotropic substances. Moreover, glutethimide is used to prevent jaundice in newborns and reduce muscle tremors.

This report contains market size and forecasts of Glutethimide in Global, including the following market information:

Global Glutethimide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Glutethimide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glutethimide include Pfizer, Abbott Laboratories, Mankind Pharma, Glaxosimithkine, Sanofi, Novartis, Abbvie, Bristol Mayers Squibb and Astrazeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glutethimide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glutethimide Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Glutethimide Market Segment Percentages, by Type, 2021 (%)

• Tablets
• Injection
• Capsules

Global Glutethimide Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Glutethimide Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Glutethimide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Glutethimide Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glutethimide revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Glutethimide revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Abbott Laboratories
• Mankind Pharma
• Glaxosimithkine
• Sanofi
• Novartis
• Abbvie
• Bristol Mayers Squibb
• Astrazeneca
• Agilent Technologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glutethimide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glutethimide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLUTETHIMIDE OVERALL MARKET SIZE

2.1 Global Glutethimide Market Size: 2021 VS 2028
2.2 Global Glutethimide Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Glutethimide Players in Global Market
3.2 Top Global Glutethimide Companies Ranked by Revenue
3.3 Global Glutethimide Revenue by Companies
3.4 Top 3 and Top 5 Glutethimide Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glutethimide Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glutethimide Players in Global Market
  3.6.1 List of Global Tier 1 Glutethimide Companies
  3.6.2 List of Global Tier 2 and Tier 3 Glutethimide Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Glutethimide Market Size Markets, 2021 & 2028
  4.1.2 Tablets
  4.1.3 Injection
  4.1.4 Capsules
4.2 By Type - Global Glutethimide Revenue & Forecasts
  4.2.1 By Type - Global Glutethimide Revenue, 2017-2022
  4.2.2 By Type - Global Glutethimide Revenue, 2023-2028
  4.2.3 By Type - Global Glutethimide Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glutethimide Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Glutethimide Revenue & Forecasts
  5.2.1 By Application - Global Glutethimide Revenue, 2017-2022
  5.2.2 By Application - Global Glutethimide Revenue, 2023-2028
  5.2.3 By Application - Global Glutethimide Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glutethimide Market Size, 2021 & 2028
6.2 By Region - Global Glutethimide Revenue & Forecasts
  6.2.1 By Region - Global Glutethimide Revenue, 2017-2022
  6.2.2 By Region - Global Glutethimide Revenue, 2023-2028
  6.2.3 By Region - Global Glutethimide Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Glutethimide Revenue, 2017-2028
  6.3.2 US Glutethimide Market Size, 2017-2028
  6.3.3 Canada Glutethimide Market Size, 2017-2028
  6.3.4 Mexico Glutethimide Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Glutethimide Revenue, 2017-2028
  6.4.2 Germany Glutethimide Market Size, 2017-2028
  6.4.3 France Glutethimide Market Size, 2017-2028
  6.4.4 U.K. Glutethimide Market Size, 2017-2028
  6.4.5 Italy Glutethimide Market Size, 2017-2028
  6.4.6 Russia Glutethimide Market Size, 2017-2028
  6.4.7 Nordic Countries Glutethimide Market Size, 2017-2028
  6.4.8 Benelux Glutethimide Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Glutethimide Revenue, 2017-2028
  6.5.2 China Glutethimide Market Size, 2017-2028
  6.5.3 Japan Glutethimide Market Size, 2017-2028
  6.5.4 South Korea Glutethimide Market Size, 2017-2028
  6.5.5 Southeast Asia Glutethimide Market Size, 2017-2028
  6.5.6 India Glutethimide Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Glutethimide Revenue, 2017-2028
  6.6.2 Brazil Glutethimide Market Size, 2017-2028
  6.6.3 Argentina Glutethimide Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Glutethimide Revenue, 2017-2028
  6.7.2 Turkey Glutethimide Market Size, 2017-2028
  6.7.3 Israel Glutethimide Market Size, 2017-2028
  6.7.4 Saudi Arabia Glutethimide Market Size, 2017-2028
  6.7.5 UAE Glutethimide Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Glutethimide Major Product Offerings
  7.1.4 Pfizer Glutethimide Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Glutethimide Major Product Offerings
  7.2.4 Abbott Laboratories Glutethimide Revenue in Global Market (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 Mankind Pharma
  7.3.1 Mankind Pharma Corporate Summary
  7.3.2 Mankind Pharma Business Overview
  7.3.3 Mankind Pharma Glutethimide Major Product Offerings
  7.3.4 Mankind Pharma Glutethimide Revenue in Global Market (2017-2022)
  7.3.5 Mankind Pharma Key News
7.4 Glaxosimithkine
  7.4.1 Glaxosimithkine Corporate Summary
  7.4.2 Glaxosimithkine Business Overview
  7.4.3 Glaxosimithkine Glutethimide Major Product Offerings
  7.4.4 Glaxosimithkine Glutethimide Revenue in Global Market (2017-2022)
  7.4.5 Glaxosimithkine Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Glutethimide Major Product Offerings
  7.5.4 Sanofi Glutethimide Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Glutethimide Major Product Offerings
  7.6.4 Novartis Glutethimide Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Abbvie
  7.7.1 Abbvie Corporate Summary
  7.7.2 Abbvie Business Overview
  7.7.3 Abbvie Glutethimide Major Product Offerings
  7.7.4 Abbvie Glutethimide Revenue in Global Market (2017-2022)
  7.7.5 Abbvie Key News
7.8 Bristol Mayers Squibb
  7.8.1 Bristol Mayers Squibb Corporate Summary
  7.8.2 Bristol Mayers Squibb Business Overview
  7.8.3 Bristol Mayers Squibb Glutethimide Major Product Offerings
  7.8.4 Bristol Mayers Squibb Glutethimide Revenue in Global Market (2017-2022)
  7.8.5 Bristol Mayers Squibb Key News
7.9 Astrazeneca
  7.9.1 Astrazeneca Corporate Summary
  7.9.2 Astrazeneca Business Overview
  7.9.3 Astrazeneca Glutethimide Major Product Offerings
  7.9.4 Astrazeneca Glutethimide Revenue in Global Market (2017-2022)
  7.9.5 Astrazeneca Key News
7.10 Agilent Technologies
  7.10.1 Agilent Technologies Corporate Summary
  7.10.2 Agilent Technologies Business Overview
  7.10.3 Agilent Technologies Glutethimide Major Product Offerings
  7.10.4 Agilent Technologies Glutethimide Revenue in Global Market (2017-2022)
  7.10.5 Agilent Technologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Glutethimide Market Opportunities & Trends in Global Market
Table 2. Glutethimide Market Drivers in Global Market
Table 3. Glutethimide Market Restraints in Global Market
Table 4. Key Players of Glutethimide in Global Market
Table 5. Top Glutethimide Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glutethimide Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glutethimide Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glutethimide Product Type
Table 9. List of Global Tier 1 Glutethimide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glutethimide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glutethimide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glutethimide Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glutethimide Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glutethimide Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glutethimide Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glutethimide Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glutethimide Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glutethimide Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glutethimide Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glutethimide Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glutethimide Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glutethimide Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glutethimide Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glutethimide Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glutethimide Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glutethimide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glutethimide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glutethimide Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glutethimide Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Glutethimide Product Offerings
Table 32. Pfizer Glutethimide Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Glutethimide Product Offerings
Table 35. Abbott Laboratories Glutethimide Revenue (US$, Mn), (2017-2022)
Table 36. Mankind Pharma Corporate Summary
Table 37. Mankind Pharma Glutethimide Product Offerings
Table 38. Mankind Pharma Glutethimide Revenue (US$, Mn), (2017-2022)
Table 39. Glaxosimithkine Corporate Summary
Table 40. Glaxosimithkine Glutethimide Product Offerings
Table 41. Glaxosimithkine Glutethimide Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Glutethimide Product Offerings
Table 44. Sanofi Glutethimide Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Glutethimide Product Offerings
Table 47. Novartis Glutethimide Revenue (US$, Mn), (2017-2022)
Table 48. Abbvie Corporate Summary
Table 49. Abbvie Glutethimide Product Offerings
Table 50. Abbvie Glutethimide Revenue (US$, Mn), (2017-2022)
Table 51. Bristol Mayers Squibb Corporate Summary
Table 52. Bristol Mayers Squibb Glutethimide Product Offerings
Table 53. Bristol Mayers Squibb Glutethimide Revenue (US$, Mn), (2017-2022)
Table 54. Astrazeneca Corporate Summary
Table 55. Astrazeneca Glutethimide Product Offerings
Table 56. Astrazeneca Glutethimide Revenue (US$, Mn), (2017-2022)
Table 57. Agilent Technologies Corporate Summary
Table 58. Agilent Technologies Glutethimide Product Offerings
Table 59. Agilent Technologies Glutethimide Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Glutethimide Segment by Type in 2021
Figure 2. Glutethimide Segment by Application in 2021
Figure 3. Global Glutethimide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glutethimide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glutethimide Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glutethimide Revenue in 2021
Figure 8. By Type - Global Glutethimide Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glutethimide Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glutethimide Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glutethimide Revenue Market Share, 2017-2028
Figure 12. US Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glutethimide Revenue Market Share, 2017-2028
Figure 16. Germany Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 17. France Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glutethimide Revenue Market Share, 2017-2028
Figure 24. China Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 28. India Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glutethimide Revenue Market Share, 2017-2028
Figure 30. Brazil Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glutethimide Revenue Market Share, 2017-2028
Figure 33. Turkey Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glutethimide Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mankind Pharma Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Glaxosimithkine Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbvie Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol Mayers Squibb Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astrazeneca Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agilent Technologies Glutethimide Revenue Year Over Year Growth (US$, Mn) & (2017-2022)